SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (490)3/17/1999 1:58:00 PM
From: Bull-like  Read Replies (2) | Respond to of 642
 
oh, this is way too dirty. This brokerage game is getting old.

from yahoo news:

"After a delayed opening, shares of Eli Lilly (NYSE:LLY - news)
traded down $4 to $90 after a report from SG Cowen said that
1999 sales of Prozac would be below its earlier estimate. The
new estimate pegs Prozac sales at $2.9 billion, a 4% reduction
from the original estimate of $3.1 billion. Lilly officials said it is
still comfortable with the $2.31 per share earnings estimate for
1999. "

Da bull